ARTICLES BY CHRISTOPHER OHMS
-
![International shipping logistics warehouse management-GettyImages-1338845747]( "The 4 Technologies Poised To Transform The Pharmaceutical Supply Chain In 2025 And Beyond")
The 4 Technologies Poised To Transform The Pharmaceutical Supply Chain In 2025 And Beyond12/2/2024These key technological advancements will significantly impact the pharma/biotech supply chain in 2025 and beyond. If you aren't implementing any of them yet, you may want to rethink your plans.
-
![earth globe judge gavel-GettyImages-984611700]( "Is The BIOSECURE Act The First Real Step Toward Reshoring?")
Is The BIOSECURE Act The First Real Step Toward Reshoring?11/22/2024The U.S. pharma industry has relied heavily on China and India to produce regulatory starting materials and APIs. The BIOSECURE Act has now emerged. Is this the first real step toward reshoring?
-
![GettyImages-1384056444 Get Ready]( "3 Focus Areas To Transition From Clinical To Commercial Readiness")
3 Focus Areas To Transition From Clinical To Commercial Readiness11/12/2024Transitioning from clinical-stage operations to commercial readiness is a multifaceted process. Establish compliant and robust distribution systems by focusing on these three areas.
Christopher Ohms
Christopher Ohms is a consultant at Ohms Consulting and is a San Francisco Bay Area native. He has held positions at Gilead Sciences, Patheon, Stanford School of Medicine, Pain Therapeutics, and ALZA. His career spanning more than 27 years in the medical and pharmaceutical settings has been in quality, project management, research, development, commercial operations, manufacturing, packaging and labeling, supply chain, sales and operations planning, and global clinical/commercial contracted relationships and oversight. Ohms has co-authored eight patents and holds a B.S. in biology and an M.A. in English literature.